TRK-IN-26

• Description:

  TRK-IN-26 (compound 12) is a TRK inhibitor with potential for cancer research[1].

• UNSPSC:

  12352005

• Target:

  Trk Receptor

• Type:

  Reference compound

• Related Pathways:

  Neuronal Signaling; Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/trk-in-26.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC=C(N(C2=CC=C(C=C2)F)C1=O)OC)NC3=CC=C(C(F)=C3)OC4=CC5=C(C=C4C6=CNN=C6)N(C)N=C5

• Molecular Formula:

  C30H22F2N6O4

• Molecular Weight:

  568.53

• References & Citations:

  [1]Boyu Zhong, et al. Trk inhibitor as anti-cancer drug. Patent WO2020048455A1.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2412309-52-3]